spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  American Academy of Dermatology 

 HSMN NewsFeed - 31 Oct 2023
FDA Approves Novartis Cosentyx(R) as the First New Biologic Treatment Option for Hidradenitis Suppurativa Patients in Nearly a Decade
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Sep 2021
FDA Approves LEXETTE (R) for Adolescent Plaque Psoriasis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 22 Apr 2021
Ortho Dermatologics Announces Statistically Significant Topline Results From Second Pivotal Phase 3 Clinical Trial Evaluating IDP-126 Gel In Acne Vulgaris
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 24 Jul 2020
Bimekizumab Superior to Cosentyx(R) in Achieving Complete Psoriasis Skin Clearance
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 17 Jul 2020
Lilly's Mirikizumab Superior to Cosentyx(R) (secukinumab) in a Phase 3 Study for Patients with Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 23 Jun 2020
Ortho Dermatologics Launches ARAZLO(TM) (tazarotene) Lotion, 0.045%, In The United States
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 18 Jun 2020
Almirall Announces FDA Approval Of Updated Label For Seysara(R) (Sarecycline) Tablets
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 1 Apr 2020
Soliton Announces New Launch Plan of Next Generation Acoustic Shockwave Product Due to COVID-19
Devices Dermatology Product Launch
 HSMN NewsFeed - 30 Mar 2020
Lilly's Taltz(R) (ixekizumab) Receives U.S. FDA Approval for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 3 Oct 2019
New Head-to-Head Data Show Taltz(R) (ixekizumab) Superiority versus TREMFYA(R) (guselkumab) in People with Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 11 Jun 2019
Lilly to Present 5-Year Sustained Efficacy and Safety Results for Taltz(R) (ixekizumab) in Patients with Plaque Psoriasis at the World Congress of Dermatology
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 22 May 2019
FDA Approves SORILUX(R) for Adolescent Plaque Psoriasis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 13 Mar 2019
Alvotech Enrolls First Patient in Clinical Phase III Study Involving Biosimilar Version of HUMIRA(R)
Biopharmaceuticals Generics Dermatology
 HSMN NewsFeed - 1 Mar 2019
AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI(TM)) for the Treatment of Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 26 Oct 2018
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
Biopharmaceuticals Dermatology Acquisitions
 HSMN NewsFeed - 10 Sep 2018
Lilly Announces Initiation of IXORA-R Head-to-Head Trial Comparing Taltz(R) and Tremfya(R) in Patients with Moderate-to-Severe Plaque Psoriasis
Biopharmaceuticals
 HSMN NewsFeed - 24 Aug 2018
Ortho Dermatologics Receives FDA Approval For ALTRENO(TM) (tretinoin 0.05%) Lotion For Acne
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 19 Feb 2018
AAD 2018: Treatment with Lilly's Taltz(R) (ixekizumab) Resulted in Improvement in Impact of Genital Psoriasis on Sexual Activity
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 22 Jan 2018
Hologic's Cynosure Division Launches TempSure(TM) Envi
Devices Dermatology Product Launch
 HSMN NewsFeed - 21 Sep 2017
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 27 Jul 2017
Valeant Announces U.S. Launch of SILIQ(TM) (brodalumab) Injection
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 21 Jul 2017
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 13 Jul 2017
DermTech Secures Billing Codes for its Proprietary Melanoma Test
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 24 May 2017
Sun Pharma Announces US FDA Filing Acceptance of Biologics License Application (BLA) For Tildrakizumab
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 24 Mar 2017
FDA Grants Approval for BAVENCIO(R) (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA Product Launch
 HSMN NewsFeed - 3 Jan 2017
Dermira Initiates Phase 3 Clinical Program in Acne
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 16 Dec 2016
Janssen Submits Application Seeking FDA Approval of STELARA(R) (Ustekinumab) for the Treatment of Adolescents with Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 16 Nov 2016
Aclaris Therapeutics Announces Positive Top-Line Phase 3 Results for A-101 In Treating Seborrheic Keratosis, a Common Undertreated Skin Condition
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 31 Oct 2016
European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 26 Feb 2016
Lilly Receives Positive CHMP Opinion for Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Sep 2015
AbbVie's HUMIRA(R) (Adalimumab) Receives First and Only U.S. Food and Drug Administration Approval for Moderate to Severe Hidradenitis Suppurativa
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 10 Jul 2015
Brickell Biotech Announces Appointment of Industry Veteran Patricia Walker, MD, PhD as President and Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Mar 2014
ZELTIQ(R) Aesthetics Launches CoolSmooth(TM) Applicator
Devices Dermatology Product Launch
 HSMN NewsFeed - 20 Mar 2014
Cutera Introduces Two New Laser Systems
Devices Dermatology Product Launch
 HSMN NewsFeed - 21 Nov 2013
Lithera Announces Appointment of Dermatology and Aesthetics Authority Dr. Lincoln Krochmal as Chief Medical Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 12 Nov 2013
Myriad Genetics Launches myPath(TM) Melanoma Diagnostic Test
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 3 Oct 2013
Valeant Pharmaceuticals Announces Approval Of Jublia(R) For The Treatment Of Onychomycosis In Canada
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 14 May 2013
Suneva Medical Announces Results of Its Pivotal ArteFill(R) Acne Scar Study
Devices Dermatology
 HSMN NewsFeed - 26 Jan 2012
LEO Pharma Announces That Picato(R) (ingenol mebutate) gel has Been Approved by US FDA for Once-Daily, 2 or 3 day Treatment of Actinic Keratoses
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 25 Jan 2012
FDA Approves Picato(R) (ingenol mebutate) Gel, the First and Only Topical Actinic Keratosis (AK) Therapy With 2 or 3 Consecutive Days of Once-Daily Dosing
Biopharmaceuticals Drug Delivery Dermatology FDA
 HSMN NewsFeed - 3 Aug 2011
Restoration Robotics Receives $41 Million in Series C Financing
Devices Dermatology Venture Capital
 HSMN NewsFeed - 14 Apr 2011
ARTAS System Receives FDA Clearance for Ground-Breaking Technology Treating Hair Loss
Devices FDA
 HSMN NewsFeed - 3 Feb 2011
Cynosure Expands Body Shaping Treatment Platform with Asset Acquisition of Eleme Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 13 Dec 2010
Lilly Suspends Phase III Trial in Metastatic Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 May 2010
STELARA(TM) Significantly Improves Symptoms of Depression, Anxiety and Health-Related Quality of Life in Patients With Moderate to Severe Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 5 Mar 2010
Levia(R) Brings Personal Targeted Phototherapy Home as a Treatment Option for Millions of Psoriasis Patients
Devices Dermatology
 HSMN NewsFeed - 23 Feb 2010
Study Showed Sculptra(R) Aesthetic Effectively Corrects Nasolabial Folds and Other Facial Wrinkles
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 12 Mar 2009
Electro-Optical Sciences Announces Additional Data From MelaFind(R) Pivotal Study Presented at American Academy of Dermatology Meeting
Devices Diagnostics Dermatology
 HSMN NewsFeed - 6 Mar 2009
Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 6 Mar 2009
BioForm Medical to Launch New 1.5cc RADIESSE(r) Volume Advantage Syringe and 0.8cc RADIESSE Moderate Fill Syringe; Announces Successful Results of RADIESSE Dermal Filler With Lidocaine Clinical Study
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 5 Mar 2009
Pyratine XR(TM) Launches at 67th AAD Meeting, Offering Hope to 14 Million Rosacea Sufferers
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 5 Mar 2009
Aesthera Announces Breakthrough Innovations at 2009 American Academy of Dermatology (AAD) Meeting
Devices Dermatology
 HSMN NewsFeed - 5 Mar 2009
Cynosure Launches New Workstation and Technology Innovations at American Academy of Dermatology Annual Meeting
Devices Dermatology
 HSMN NewsFeed - 5 Mar 2009
Lumenis(R) Introduces LightSheer(R) Duet(TM) for High Speed Permanent Hair Reduction
Devices Dermatology
 HSMN NewsFeed - 17 Feb 2009
Syneron(TM) Partners With the American Academy of Cosmetic Physicians (AAOCP) to Train LipoLite(TM) and Laser LipoSculpture Physicians
Devices
 HSMN NewsFeed - 20 Oct 2008
Avidas Pharmaceuticals Launches Vitaphenol(R)
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 10 Oct 2008
Excaliard Pharmaceuticals Appoints Lincoln Krochmal, MD, President & Chief Executive Officer and Jeffrey Jenson, Head of Clinical Operations.
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 22 May 2008
Barrier Therapeutics Announces Agreement with Procter & Gamble to Market Xolegel (ketoconazole, USP) Gel, 2 Percent With Head & Shoulders Shampoo as Xolegel Duo
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 21 May 2008
American Academy of Dermatology Issues New Guidelines for the Management of Psoriasis and Psoriatic Arthritis
Dermatology
 HSMN NewsFeed - 6 Mar 2008
Onset Therapeutics Announces Launch of Anestafoam(TM), a Novel Topical Anesthetic Foam
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 4 Feb 2008
Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 3 Feb 2008
New Technology and Improved Techniques Arm Dermatologists With Tools to Minimize Facial Scars From Skin Cancer Surgery
Dermatology
 HSMN NewsFeed - 3 Feb 2008
American Academy of Dermatology Research Confirms Genetic Skin Barrier Defect Linked to Eczema
Dermatology
 HSMN NewsFeed - 1 Feb 2008
Obagi Medical Products' Solubilized Benzoyl Peroxide Provides Clinically Significant Lesion Reduction for Mild to Moderately Severe Acne
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 1 Feb 2008
Thermage Introduces Cellulite Product
Devices Dermatology
 HSMN NewsFeed - 1 Feb 2008
Thermage Introduces Infinity Program at AAD
Devices Dermatology
 HSMN NewsFeed - 31 Jan 2008
Syneron(TM) Previews Matrix RF(TM) Ablative Fractional Device and Laser-Assisted Lipolysis System at American Academy of Dermatology Annual Meeting
Devices Dermatology
 HSMN NewsFeed - 31 Jan 2008
Cynosure Launches Three Aesthetic Products at American Academy of Dermatology 2008 Annual Meeting
Devices Dermatology
 HSMN NewsFeed - 19 Jan 2008
Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Nov 2007
Bradley Pharmaceuticals Launches ROSULA(R) CLK(TM)
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 23 Oct 2007
New Data Show Obagi Medical Products' Nu-Derm Improves Scar Cosmesis Following Removal of Basal Cell Carcinoma versus Standard Treatment
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 2 Aug 2007
Barrier Therapeutics Introduces New Xolegel Duo(TM) Offering at the American Academy of Dermatology (AAD) Summer Academy Meeting 2007
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 2 Aug 2007
Obagi Medical Products' New Study Shows CLENZIderm M.D. is Clinically Effective in the Treatment of Acne at Both Once- and Twice-Daily Dosing
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 1 Aug 2007
American Academy of Dermatology Says New Technologies Tighten Skin From Head to Toe Without Surgery
Devices Dermatology
 HSMN NewsFeed - 1 Aug 2007
American Academy of Dermatology Says Research Shows Incidence of Melanoma on the Rise
Dermatology Oncology
 HSMN NewsFeed - 20 Jun 2007
FDA Approves Differin(R) (adapalene) Gel, 0.3% for Acne
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 29 May 2007
Talima Therapeutics Secures $19 Million Series B
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 7 May 2007
New Study Identifies Five Risk Factors Linked to Melanoma Detection
Dermatology Oncology
 HSMN NewsFeed - 7 May 2007
Dermatologists Warn Myths About Melanoma Could Lead to Delayed Diagnosis and Treatment
Dermatology Oncology
 HSMN NewsFeed - 30 Apr 2007
Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory Dose Doxycycline for the Treatment of Rosacea
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 12 Mar 2007
Sanofi-Aventis Debuts AgingWithBeauty.com
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 8 Feb 2007
Isolagen, Inc. Names Sandra Calman, M.D. Vice President of Clinical Development and Chief Medical Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 7 Feb 2007
JSJ Pharmaceuticals Assumes Sales & Marketing Responsibility of Oxsoralen-Ultra(R) from Valeant Pharmaceuticals International
Biopharmaceuticals
 HSMN NewsFeed - 2 Feb 2007
Survey Indicates People with Chronic Moderate to Severe Plaque Psoriasis May Be Under-Treated
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 2 Feb 2007
Thermage Pioneers Non-Invasive Procedure to Tighten Skin for Younger Looking Hands
Devices Dermatology
 HSMN NewsFeed - 2 Feb 2007
Genentech Announces Positive Results from a Phase IV Study of Raptiva in Patients With Moderate-to-Severe Hand and Foot Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 2 Feb 2007
Psoriasis Patients Show Significant Improvement in Symptoms with Abbott's HUMIRA(R) in New Phase III Study
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 2 Feb 2007
New Analyses Reinforce Efficacy of REMICADE(R) in Treatment of Severe Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 2 Feb 2007
REMICADE(R) Therapy Shown to Improve Productivity in Patients Treated for Chronic Plaque Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 2 Feb 2007
AGI Dermatics Presents Comparative Data That Indicates L-ergothioneine (EGT) Reduces UVA340-Induced Hydrogen Peroxide More Efficiently Than Idebenone
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 2 Feb 2007
AGI Dermatics Data Shows Efficacy of Bicyclic Monoterpene Diols in Treatment of Molecular Markers of PhotoAged Skin
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 2 Feb 2007
Anacor Signs Worldwide Exclusive License Agreement With Schering-Plough for AN2690, a New Topical Anti-Fungal Treatment
Biopharmaceuticals Licensing
 HSMN NewsFeed - 2 Feb 2007
Cynosure Expands Anti-Aging Aesthetic Solution With Introduction of Deep-Heating Wavelength for Affirm(TM) Workstation
Devices Dermatology
 HSMN NewsFeed - 2 Feb 2007
Positive Results of Phase 4 Clinical Study Evaluating Effects of Oracea(TM) (doxycycline, USP) Capsules, 40 mg, in Combination with MetroGel(R) (metronidazole gel), 1%, as Treatment for Rosacea Presented at Annual Meeting of the AAD
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 1 Feb 2007
Thermage(R), Inc. Drives Advances in Non-Invasive Aesthetic Market Through Introduction of ThermaCool(R) NXT
Devices Dermatology
 HSMN NewsFeed - 1 Feb 2007
Artes Medical Announces Landmark Five Year Study Results for ArteFill, a Non-Resorbable Dermal Filler
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 31 Jan 2007
Cutera Introduces Novel Laser Wavelength for Cosmetic Dermatology
Devices Dermatology
 HSMN NewsFeed - 31 Jan 2007
Virabiotic's MolluscuDerm(TM) Topical Antiviral Therapy Launches at American Academy of Dermatology Meeting Feb. 2-5, 2007
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 23 Jan 2007
DUSA Pharmaceuticals, Inc.: International Guidelines Recommend Photodynamic Therapy as First-Line Treatment for Actinic Keratoses
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 18 Jan 2007
Candela Secures Exclusive Rights to Develop Tattoo Removal Device for Freedom-2 Tattoos
Devices Dermatology
Return to NewsFeed  

 Additional items found! 94

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 94 additional stories matching:
American Academy of Dermatology
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.